Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Deals & business · first seen 10h ago, updated 10h ago

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

1 outlet CAR-T & cell therapy

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies